Fate Therapeutics Inc (FATE)
3.785
-0.08
(-2.20%)
USD |
NASDAQ |
Apr 26, 15:16
Fate Therapeutics Price to Book Value: 1.020 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 1.042 |
| April 24, 2024 | 1.158 |
| April 23, 2024 | 1.223 |
| April 22, 2024 | 1.288 |
| April 19, 2024 | 1.290 |
| April 18, 2024 | 1.358 |
| April 17, 2024 | 1.420 |
| April 16, 2024 | 1.449 |
| April 15, 2024 | 1.519 |
| April 12, 2024 | 1.554 |
| April 11, 2024 | 1.603 |
| April 10, 2024 | 1.689 |
| April 09, 2024 | 1.821 |
| April 08, 2024 | 1.807 |
| April 05, 2024 | 1.864 |
| April 04, 2024 | 1.878 |
| April 03, 2024 | 1.888 |
| April 02, 2024 | 1.832 |
| April 01, 2024 | 1.907 |
| March 28, 2024 | 1.977 |
| March 27, 2024 | 1.977 |
| March 26, 2024 | 1.848 |
| March 25, 2024 | 1.850 |
| March 22, 2024 | 1.780 |
| March 21, 2024 | 2.001 |
| Date | Value |
|---|---|
| March 20, 2024 | 2.001 |
| March 19, 2024 | 1.886 |
| March 18, 2024 | 1.896 |
| March 15, 2024 | 2.018 |
| March 14, 2024 | 1.948 |
| March 13, 2024 | 2.058 |
| March 12, 2024 | 2.063 |
| March 11, 2024 | 2.125 |
| March 08, 2024 | 2.187 |
| March 07, 2024 | 2.249 |
| March 06, 2024 | 2.150 |
| March 05, 2024 | 1.867 |
| March 04, 2024 | 1.907 |
| March 01, 2024 | 2.085 |
| February 29, 2024 | 1.910 |
| February 28, 2024 | 1.923 |
| February 27, 2024 | 2.010 |
| February 26, 2024 | 1.872 |
| February 23, 2024 | 1.875 |
| February 22, 2024 | 1.853 |
| February 21, 2024 | 1.840 |
| February 20, 2024 | 1.902 |
| February 16, 2024 | 2.024 |
| February 15, 2024 | 1.895 |
| February 14, 2024 | 1.737 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4039
Minimum
Oct 27 2023
28.35
Maximum
Jan 14 2021
6.581
Average
5.788
Median
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 18.88 |
| Regeneron Pharmaceuticals Inc | 3.729 |
| Sarepta Therapeutics Inc | 14.19 |
| ADMA Biologics Inc | 11.09 |
| Ocular Therapeutix Inc | 7.682 |
Price to Book Value Related Metrics
| PS Ratio | 5.863 |
| Price | 3.785 |
| Earnings Yield | -43.33% |
| Market Cap | 375.61M |